1. Home >
  2. Companies >
  3. Life Science >
  4. United States >
  5. California >
  6. iBio

iBio - M&A Summary and Business Overview

Life ScienceCompany

iBio M&A Summary

iBio has acquired 1 company, including 1 in the last 5 years. It has also divested 1 asset.

It’s largest disclosed sale occurred in 2024, when it sold iBio - Preclinical PD-1 Agonist Antibody Program to Otsuka Pharmaceutical for $53M. iBio has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).

iBio Business Overview

Where is iBio headquartered?

iBio is headquartered in San Diego, California.

What is iBio’s revenue?

iBio disclosed revenue of 2M USD for 2022 and 2M USD for 2021.

How many employees does iBio have?

iBio has 16 employees.

What sector is iBio in?

iBio is a life science company.

When was iBio founded?

iBio was founded in 2008.

M&A Summary

  • M&A Total Activity2
    • M&A Buy Activity1
    • M&A Sell Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 1

iBio

iBio, Inc.

11750 Sorrento Valley Road, Suite 200,
San Diego, California 92121
United States,
(979) 446-0027
www.ibioinc.com

iBio develops next-generation biopharmaceuticals using computational biology and 3D-modeling of hard-to-target subdominant epitopes along with its sustainable, plant-based protein expression capabilities for cGMP manufacturing. iBio was founded in 2008 and is based in San Diego, California.


M&A Summary

Buy vs Sell

Year ≤ '20 '21 '22 '23 '24 '25 T
Buy (0.2/yr) # - - 1 - - - 1
Sell (0.2/yr) # - - - - 1 - 1
vol $53M $53M
  2

Most Recent M&A

Company Date Value Type
iBio - Preclinical PD-1 Agonist Antibody Program 2024-02-25 53M USD Divestiture
Bryan, Texas
RubrYc Therapeutics, Inc. 2022-09-21 - Add-on Acquisition
San Carlos, California · www.rubryc.com
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 1 (100%) - 1 (100%) 53M (100%)
Total 1 - 1 $53M

By Geo

State/Country Buy Value Sell Value
United States 1 - 1 53M
  California 1 - - -
  Texas - - 1 53M
Total 1 - 1 $53M

Deal Values

sell # Total
< $100M 1 $53M
TOTAL $53M
Largest iBio - Preclinical PD-1 Agonist Antibody Program
$53M (2024-02-25)

M&A Connections

Deals
Divested to
Strategic(s)
100%
1 (100%)

Company Summary

SECTOR

Life Science

Revenue

2   0% 2022
2   0% 2021
2   0% 2020
2   2019
(millions of USD) Show More Show Less

Employees

16

Established

2008

Public

NASDAQ: IBIO

 Subscribe to unlock this and 215,016
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
Get Full Access

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore a company's M&A activity, ownership history, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.7K Private Equity Firms
  • 208K M&A Transactions
  • 210K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

What next?

Get Full Access

Full access to Mergr's investor, acquirer, and transaction data starts here.

Related Lists for iBio

Life Science Companies

Related Lists for Life Science Companies

Largest Life Science Companies , Acquisitive Life Science Companies , Recently Acquired Life Science Companies , Recently Sold Life Science Companies , Private Life Science Companies , Public Life Science Companies , Acquired Life Science Companies , PE Backed Life Science Companies
Mergr

Solution for

Product

Company

Legal